文献速递药物不良反应与药物警戒治疗药物监测与药物基因组学

HLA等位基因与KIR类型对肝素诱导性血小板减少症的影响

Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT).
PubMed 文献 · Pharmacotherapy · 2017-09-04

结果显示HLA-DRB3*01:01等位基因与HIT显著相关(OR 2.81 [1.57-5.02],p=2.1×10-4,q=0.02),未发现KIR类型与HIT独立相关,但KIR2DS5与HLA-C1配体组存在显著交互作用(p=0.03)。

要点

  • HLA-DRB3*01:01等位基因与HIT风险显著相关(OR 2.81 [1.57-5.02])。
  • 未发现KIR类型单独与HIT显著相关。
  • KIR2DS5与HLA-C1结合组交互作用显著(p=0.03)。

核心结论

  • HLA-DRB3*01:01等位基因可能是HIT的潜在风险因素,KIR类型在HIT发病中的作用证据有限。

主要发现

  • 在总体人群中,HLA-DRB3*01:01与HIT显著相关(OR 2.81 [1.57-5.02],p=2.1×10-4,q=0.02),在欧洲裔个体中亦独立相关。
  • 未发现任何KIR类型与HIT独立相关。
  • 观察到KIR2DS5与HLA-C1 KIR结合组之间存在显著交互作用(p=0.03)。

关键数值与推荐

  • HLA等位基因和KIR类型关联分析的FDR校正阈值为q<0.05。
  • HLA*KIR交互作用显著性阈值设为p<0.05。
  • 分析仅纳入频率大于0.01的KIR类型和HLA等位基因。

临床怎么用

  • HLA-DRB3*01:01可能作为HIT风险分层候选标志物,但需进一步验证。
  • 目前不推荐基于KIR类型进行HIT风险预测。

局限性

  • 研究结果为初步发现,HLA-DRB3*01:01与HIT的关联需在独立人群中复制验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heparin-induced thrombocytopenia (HIT) is an unpredictable, life-threatening, immune-mediated reaction to heparin. Variation in human leukocyte antigen (HLA) genes is now used to prevent immune-mediated adverse drug reactions. Combinations of HLA alleles and killer cell immunoglobulin-like receptors (KIR) are associated with multiple autoimmune diseases and infections. The objective of this study is to evaluate the association of HLA alleles and KIR types, alone or in the presence of different HLA ligands, with HIT. HIT cases and heparin-exposed controls were identified in BioVU, an electronic health record coupled to a DNA biobank. HLA sequencing and KIR type imputation using Illumina OMNI-Quad data were performed. Odds ratios for HLA alleles and KIR types and HLA*KIR interactions using conditional logistic regressions were determined in the overall population and by race/ethnicity. Analysis was restricted to KIR types and HLA alleles with a frequency greater than 0.01. The p values for HLA and KIR association were corrected by using a false discovery rate q<0.05 and HLA*KIR interactions were considered significant at p<0.05. Sixty-five HIT cases and 350 matched controls were identified. No statistical differences in baseline characteristics were observed between cases and controls. The HLA-DRB3*01:01 allele was significantly associated with HIT in the overall population (odds ratio 2.81 [1.57-5.02], p=2.1×10-4 , q=0.02) and in individuals with European ancestry, independent of other alleles. No KIR types were associated with HIT, although a significant interaction was observed between KIR2DS5 and the HLA-C1 KIR binding group (p=0.03). The HLA-DRB3*01:01 allele was identified as a potential risk factor for HIT. This class II HLA gene and allele represent biologically plausible candidates for influencing HIT pathogenesis. We found limited evidence of the role of KIR types in HIT pathogenesis. Replication and further study of the HLA-DRB3*01:01 association is necessary.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Karnes JH, Shaffer CM, Cronin R, et al. Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT). Pharmacotherapy. 2017. PMID: 28688202. doi:10.1002/phar.1983

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。